SPINK1 and cancer: We established that miR‐338‐5p and miR‐421 mediate several cellular responses against SPINK1‐positive cancer by inducing S‐phase cell‐cycle arrest, inhibiting epithelial‐to‐mesenchymal transition (EMT), cancer stemness and drug resistance.